Tag Archives: meningitis

Meningitis Research Foundations begins new study and model

Meningitis Research Foundation

TweetThe Meningitis Research Foundation said on Wednesday that it will begin research on how to assess potential Group B Streptococcal vaccines against meningitis and the impact of introducing vaccines to pregnant women. The study will be led by Caroline Trotter … Read More »

Filed in Vaccine Development | Tagged , , | Leave a comment

Bexsero receives Breakthrough Therapy designation from FDA

novartis

TweetNovartis announced on Monday that its meningococcal group B vaccine Bexsero received a Breakthrough Therapy designation from the U.S. Food and Drug Administration. The vaccine is already approved for use in the United Kingdom, Canada and Australia, and was recently … Read More »

Filed in Medical Countermeasures | Tagged , , | Leave a comment

Meningitis Research Foundation Ireland hopeful meningococcal vaccine will be approved

Meningitis Research Foundation

TweetMeningitis Research Foundation Ireland said on Wednesday that the National Immunisation Advisory Committee will make a meningococcal disease group B vaccine a priority after it was recommended for use in the U.K. The Bexsero vaccine was recommended by the Joint … Read More »

Filed in Medical Countermeasures | Tagged , , | Leave a comment

CDC confirms death from meningococcal disease at Drexel University

Meningococcal bacteria

Tweet The Center for Disease Control and Prevention said on Tuesday that a Drexel University student died on March 10 from serogroup B meningococcal disease, and the strain matches the one involved in an outbreak at Princeton University. The CDC … Read More »

Filed in Medical Countermeasures | Tagged , | Comments Off

Novartis’ Bexsero meningitis B vaccine approved for infants and adolescents in Australia

novartis

TweetNovartis recently announced that its vaccine treatment against meningococcal group B, Bexsero, gained approval in Australia for use with infants and adolescents. The Australian Technical Advisory Group on Immunisation, Australia‚Äôs governing body on immunizations, recently recommended Bexsero for all infants, … Read More »

Filed in Medical Countermeasures | Tagged , , | Comments Off

Meningitis outbreak in Uganda continues

Meningococcal bacteria

Tweet The Uganda Ministry of Health recently reported that it is responding to a meningococcal meningitis outbreak in the West Nile Sub-region of Uganda that has affected 121 persons since January 31, 2014. The outbreak affected the Adjumani and Arua … Read More »

Filed in Medical Countermeasures | Tagged , | Comments Off

Novartis’ Meningococcal B vaccine Bexsero approved for use in Canada

novartis

TweetNovartis Pharmaceuticals Canada, Inc., announced on Wednesday that its multicomponent meningococcal B vaccine Bexsero is now available in Canada. The vaccine was approved for use in persons two months to 17 years of age. Bexsero is the first vaccine to … Read More »

Filed in Vaccine Development | Tagged , | Comments Off

Novartis provides UCSB with meningitis vaccine

Meningitis

Tweet Novartis announced on Monday that it is providing the University of California at Santa Barbara with its meningococcal serogroup B vaccine, Bexsero, to vaccinate students and staff in response to a meningitis outbreak. The U.S. Food and Drug Administration … Read More »

Filed in Medical Countermeasures | Tagged , , | Comments Off

Study to examine pros and cons of meningitis vaccine in the U.K.

Meningitis vaccine could reach remote African areas

Meningitis vaccine MenAfriVac safe outside of cold chain

Princeton University holds vaccination event against meningitis B

MRF expands meningitis treatment to rural Malawi

TMR releases updated report on meningococcal vaccines market

Wolters Kluwer Health adds meningitis B vaccine to drug reference

CDC Foundation receives $13.5 million for meningitis, rotavirus vaccines

PolyDNA warns parents about viral meningitis

Health Canada approves Bexsero* Meningococcal B vaccine

Novartis supplies meningitis B vaccine to Princeton to stem outbreak

Princeton University responds to meningococcal outbreak

New DNA test shows promise for enhanced TBM diagnosis

Meningitis vaccine booster may stave off waning immunity

New meningitis vaccine dramatically reduces Chad epidemic

Meningitis Angels praise FDA’s expanded approval of Menveo

JCVI does not recommend meningitis B vaccine for immunization program

Voices of Meningitis and Sanofi Pasteur launch awareness campaign for young athletes

Surgeon discusses meningitis on Good Day L.A.

MSF conducts meningitis A vaccination campaign in South Sudan

U.N. helps South Sudan fight meningitis outbreak

Steroid injections cause meningitis infections in Michigan

MRFC brings awareness to meningitis with sky-high walk

Tennessee lawmakers sponsor meningitis requirement for public universities